Calibr-Skaggs Institute for Innovative Medicines

Grantee website La Jolla, California, United States
Purpose
to fund preclinical development of a long-acting oral formulation of EF-dA, either as a new chemical entity or as a prodrug, for pre-exposure prophylaxis of HIV infection to impact global health
Grantee
Division
Global Health
Date
NOVEMBER 2018
Region served
GLOBAL
Committed amount
$6,105,723
Grant topic
HIV
Duration (months)
54
Grantee location
La Jolla, California, United States

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.